GSK’s RSV vaccine shows long-term efficacy in late-stage trial
(Reuters) -GSK on Wednesday said its vaccine for the respiratory syncytial virus (RSV), which recently won EU approval, showed strong long-term protection in older adults …
(Reuters) -GSK on Wednesday said its vaccine for the respiratory syncytial virus (RSV), which recently won EU approval, showed strong long-term protection in older adults …
TOKYO (Reuters) -Japan is in the final stages of negotiations with the United States to buy U.S.-made Tomahawk cruise missiles, the Yomiuri daily reported on …